For more than 25 years at BUSM/BMC, Dr. Barnett has been a clinical and academic leader who has achieved international prominence in Travel and Tropical Medicine with a particular focus on refugee health and the medical needs of new immigrant families. She has served as the PI of the BMC Refugee Health Assessment Program for more than 20 years and also is Site Director for the GeoSentinel Program in partnership with the Centers for Disease Control. In addition, Dr. Barnett has studied the safety and dissemination of childhood immunizations and is a leader in the BMC Center for Immunization Safety and Assessment.
Nationally recognized for her work in Pediatric Infectious Diseases, Dr. Barnett is a member of the Committee on Infectious Diseases of the American Academy of Pediatrics, the body that publishes the Red Book, which is the authoritative text for the treatment of Pediatric Infectious Diseases. She has published more than 90 peer-reviewed manuscripts and presented at numerous national and international meetings and seminars.
Dr. Barnett completed her pediatric residency at Boston City Hospital (BCH) and Children’s Hospital, Boston. After serving as a Chief Resident in the Department of Pediatrics, she completed fellowship training in Pediatric Infectious Diseases at BCH under the direction of Drs. Pelton and Jerome Klein.
- Boston University, MD
- Brown University, SB/ScB
- Published on 8/25/2020
Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, Wachman EM. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020 10; 100:69-74. PMID: 32862058.
- Published on 3/7/2020
Taucher C, Barnett ED, Cramer JP, Eder-Lingelbach S, Jelinek T, Kadlecek V, Kiermayr S, Mills DJ, Pandis D, Reiner D, Dubischar KL. Neutralizing antibody persistence in pediatric travelers from non-JE-endemic countries following vaccination with IXIARO® Japanese encephalitis vaccine: An uncontrolled, open-label phase 3 follow-up study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101616. PMID: 32156630.
- Published on 11/9/2019
Gautret P, Angelo KM, Asgeirsson H, Duvignaud A, van Genderen PJJ, Bottieau E, Chen LH, Parker S, Connor BA, Barnett ED, Libman M, Hamer DH. International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study. Travel Med Infect Dis. 2019 Nov 09; 101504. PMID: 31707112.
- Published on 9/2/2019
Angelo KM, Libman M, Gautret P, Barnett E, Grobusch MP, Hagmann SHF, Gobbi F, Schwartz E, van Genderen PJJ, Asgeirsson H, Hamer DH. The rise in travel-associated measles infections-GeoSentinel, 2015-2019. J Travel Med. 2019 Sep 02; 26(6). PMID: 31218359.
- Published on 6/21/2019
Kohl SE, Barnett ED. What do we know about travel for children with special health care needs? A review of the literature. Travel Med Infect Dis. 2020 Mar - Apr; 34:101438. PMID: 31233860.
- Published on 4/1/2019
Epstein RL, Bhagavathula M, Saag LA, Verma S, Kan CK, Mesick J, Kamineni P, White LF, Barnett ED, Salgame P, Hochberg NS. QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA. Int J Tuberc Lung Dis. 2019 04 01; 23(4):482-490. PMID: 31064628.
- Published on 11/29/2018
Schlagenhauf P, Grobusch MP, Hamer DH, Asgeirsson H, Jensenius M, Eperon G, Rothe C, Isenring E, Fehr J, Schwartz E, Bottieau E, Barnett ED, McCarthy A, Kelly P, Schade Larsen C, van Genderen P, Stauffer W, Libman M, Gautret P. Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis. Malar J. 2018 Nov 29; 17(1):443. PMID: 30497487.
- Published on 11/13/2018
Gautret P, Angelo KM, Asgeirsson H, Lalloo DG, Shaw M, Schwartz E, Libman M, Kain KC, Piyaphanee W, Murphy H, Leder K, Vincelette J, Jensenius M, Waggoner J, Leung D, Borwein S, Blumberg L, Schlagenhauf P, Barnett ED, Hamer DH. Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis. PLoS Negl Trop Dis. 2018 11; 12(11):e0006951. PMID: 30422981.
- Published on 3/13/2018
Jelinek T, Cromer MA, Cramer JP, Mills DJ, Lessans K, Gherardin AW, Barnett ED, Hagmann SHF, Askling HH, Kiermayr S, Kadlecek V, Eder-Lingelbach S, Taucher C, Dubischar KL. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study. Travel Med Infect Dis. 2018 Mar - Apr; 22:18-24. PMID: 29549036.
- Published on 1/1/2018
Angelo KM, Haulman NJ, Terry AC, Leung DT, Chen LH, Barnett ED, Hagmann SHF, Hynes NA, Connor BA, Anderson S, McCarthy A, Shaw M, Van Genderen PJJ, Hamer DH. Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007-17. J Travel Med. 2018 01 01; 25(1). PMID: 30202952.
View 90 more publications: View full profile at BUMC